Anticancer exffect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice

Cancer Chemotherapy and Pharmacology

Volumn 44, Issue 3, 1999, Pages 177-186

  Knight, Vernon ^a   Koshkina, Nadezhda V ^a   Waldrep, J Clifford ^a   Giovanella, Beppino C ^b   Gilbert, Brian E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b St Joseph's Hospital   (United States)

Author keywords

9 Nitrocamptothecin; Aerosol; Camptothecin; Cancer; Liposome

Indexed keywords

DILAUROYLPHOSPHATIDYLCHOLINE; LIPOSOME; RUBITECAN; TERT BUTYL ALCOHOL; 9-NITROCAMPTOTHECIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG CARRIER; DRUG DERIVATIVE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; INHALATIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; LUNG CANCER; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; ELECTRON MICROSCOPY; NEOPLASM; PARTICLE SIZE; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; DRUG CARRIERS; HUMANS; LIPOSOMES; MICE; MICE, NUDE; MICROSCOPY, ELECTRON; NEOPLASM TRANSPLANTATION; NEOPLASMS; PARTICLE SIZE;

EID: 0032587355     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050965     Document Type: Article

References (33)

1. 1. Alvarez FG, Knight C, Waldrep C, Rodarte JR, Knight V, Eschenbacher WL (1997) Evaluation of the safety of cyclosporin A liposome aerosol in human subjects. Am J Respir Crit Care Med 155: A659
2. 2. Burke TG, Mi Z (1993) Preferential binding of the carboxylate form of camptothecin by human serum albumin. Anal Biochem 212: 285-287
3. 3. Burke TG, Mishra AK, Wani MC, Wall ME (1993) Lipid bilayer partitioning and stability of camptothecin drugs. Biochemistry 32: 5352-5364
4. 4. Burke TG (1996) Chemistry of the camptothecins in the bloodstream. Drug stabilization and optimization of activity. Ann NY Acad Sci 803: 29-31
5. 5. Dancey J, Eisenhauer EA (1996) Current perspectives on camptothecins in cancer treatment. Br J Cancer 74: 327-338
6. 6. Daoud SS, Fetouh MI, Giovanella BC (1995) Antitumor effect of liposome-incorporated camptothecin in human malignant xenografts. Anticancer Drugs 6: 83-93
7. 7. Erickson Miller CL, May RD, Tomaszewski J, Osborn B, Murphy MJ, Page JG, Parchment RE (1997) Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro. Cancer Chemother Pharmacol 39: 467-472
8. 8. Fairchild GA (1972) Measurement of respiratory volume for virus retention studies in mice. Appl Microbiol 24: 812-818
9. 9. Fleury F, Kudelina I, Nabiev I (1997) Interactions of lactone, carboxylate and self-aggregated forms of camptothecin with human and bovine serum albumins. FEBS Lett 406: 151-156
10. 10. Gilbert BE, Black MB, Waldrep JC, Bennick J, Montgomery C, Knight V (1997) Cyclosporin A liposome aerosol: lack of acute toxicity in rats with a high incidence of underlying pneumonitis. Inhal Toxicol 9: 717-730
11. 11. Gilbert BE, Knight C, Alvarez FG, Waldrep JC, Rodarte JR, Knight V, Eschenbacher WL (1997) Tolerance of volunteers to cyclosporine A-dilauroylphosphatidylcholine liposome aerosol. Am J Respir Crit Care Med 156: 1789-1793
12. 12. Gilbert BE, Knight V (1996) Pulmonary delivery of antiviral drugs in liposome aerosols. Semin Pediatr Infect Dis 7: 148-154
13. 13. Gilbert BE, Proffitt RT (1996) Aerosolized AmBisome treatment of pulmonary Cryptococcus neoformans infection in mice. J Aerosol Med 9: 263-276
14. 14. Gilbert BE, Wyde PR, Lopez-Berestein G, Wilson SZ (1994) Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice. Antimicrob Agents Chemother 38: 356-359
15. 15. Gilbert BE, Wyde PR, Wilson SZ (1992) Aerosolized liposomal amphotericin B for treatment of pulmonary and systemic Cryptococcus neoformans infections in mice. Antimicrob Agents Chemother 36: 1466-1471
16. 16. Giovanella BC, Hinz HR, Kozielski AJ, Stehlin JS, Silber R, Potmesil M (1991) Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin. Cancer Res 51: 3052-3055
17. 17. Giovanella BC, Natelson E, Harris N, Vardeman D, Stehlin JS (1996) Protocols for the treatment of human tumor xenografts with camptothecins. Ann NY Acad Sci 803: 181-187
18. 18. Giovanella BC, Yim SO, Stehlin JS, Williams LJ (1972) Development of invasive tumors in the "nude" mouse after injection of cultured human melanoma cells. J Natal Cancer Inst 48: 1531-1533
19. 19. Hinz HR, Harris NJ, Natelson EA, Giovanella BC (1994) Pharmacokinetics of the in vivo and in vitro conversion of 9-nitro-20(S)-camptothecin to 9-amino-20(S)-camptothecin in humans, dogs, and mice. Cancer Res 54: 3096-3100
20. 20. Knight V, Gilbert B (1988) Antiviral therapy with small particle aerosols. Eur J Clin Microbiol Infect Dis 7: 721-731
21. 21. Knight V, Yu CP, Gilbert BE, Divine GW (1988) Estimating the dosage of ribavirin aerosol according to age and other variables. J Infect Dis 158: 443-448
22. 22. Natelson EA, Giovanella BC, Verschraegen CF, Fehir KM, De Ipolyi PD, Harris N, Stehlin JS (1996) Phase I clinical and pharmacological studies of 20-(S)-camptothecin and 20-(S)-9-nitrocamptothecin as anticancer agents. Ann N Y Acad Sci 803: 224-230
23. 23. O'Riordan TG, Waldrep JC, Abraham WM, Mao Y, Sabater JR, Sielczak M, Knight V (1997) Delivery of nebulized budesonide liposomes to the respiratory tract of allergic sheep. J Aerosol Med 10: 117-128
24. 24. Pantazis P, Kozielski AJ, Mendoza JT, Early JA, Hinz HR, Giovanella BC (1993) Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non-tumorigenic and tumorigenic cells in vitro. Int J Cancer 53: 863-871
25. 25. Pantazis P, Kozielski AJ, Vardeman DM, Petry ER, Giovanella BC (1993) Efficacy of camptothecin congeners in the treatment of human breast carcinoma xenografts. Oncol Res 5: 273-281
26. 26. Pantazis P, Mendoza JT, De Jesus A, Rubin E, Kufe D, Giovanella BC (1994) Partial characterization of human leukemia U-937 cell sublines resistant to 9-nitrocamptothecin. Eur J Haematol 53: 135-144
27. 27. Pantazis P (1995) Preclinical studies of water-insoluble camptothecin congeners: cytotoxicity, development of resistance, and combination treatments. Clin Cancer Res 1: 1235-1244
28. 28. Phalen RF (1984) Inhalation studies: foundations and techniques. CRC Press, Boca Raton, p 222
29. 99mtechnetium-labelled beclomethasone dipropionate dilauroylphosphatidylcholine liposome aerosol in normal volunteers. Int J Pharm 115: 209-216
30. 30. Waldrep JC, Arppe J, Jansa KA, Knight V (1997) High dose cyclosporin A and budesonide liposome aerosols. Int J Pharm 152: 27-36
31. 31. Waldrep JC, Gilbert BE, Knight CM, Black MB, Scherer PW, Knight V, Eschenbacher W (1997) Pulmonary delivery of beclomethasone liposome aerosol in volunteers. Tolerance and safety. Chest 111: 316-323
32. 32. Waldrep JC, Scherer P, Keyhani K, Hess D, Black M, Knight V (1994) Nebulized glucocorticoids in liposomes: aerosol characteristics and human dose estimates. J Aerosol Med 7: 135-145
33. 33. Wall ME, Wani MC (1995) Camptothecin and taxol: discovery to clinic - Thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res 55: 753-760